Polypropylene resin composition
    3.
    发明授权
    Polypropylene resin composition 失效
    聚丙烯树脂组合物

    公开(公告)号:US5238989A

    公开(公告)日:1993-08-24

    申请号:US820668

    申请日:1992-01-16

    CPC分类号: C08K3/346 C08K3/34 C08K7/14

    摘要: The present invention provides a polypropylene resin composition which permits the formation of materials having high strength and stiffness, less warpage deformation and such excellent mechanical durability that these materials can be used when load is applied continuously for a long term or when load is applied repeatedly.The polypropylene resin composition contains the three components of (a) 40 to 75% by weight of a modified polypropylene obtained by heating and melting a mixture prepared by adding at least (1) 0.01 to 2% by weight of an unsaturated acid, (2) 0.1 to 3% by weight of an unsaturated silane and (3) an organic peroxide to a crystalline polypropylene, (b) 10 to 35% by weight of glass fibers, and (c) 15 to 45% by weight of a mica powder, and the components (b) and (c) are blended with the component (a) so that the total amount of the components (b) and (c) may be in the range of from 25 to 60% by weight based on the composition.

    摘要翻译: PCT No.PCT / JP91 / 00668 Sec。 371日期:1992年1月16日 102(e)日期1992年1月16日PCT提交1991年5月20日PCT公布。 出版物WO91 / 18049 日本1991年11月28日。本发明提供了一种聚丙烯树脂组合物,其能够形成具有高强度和刚度,较少翘曲变形的材料,并且具有这样的优异的机械耐久性,当长期连续施加负载时可以使用这些材料 或当重复施加负载时。 聚丙烯树脂组合物含有(a)40〜75重量%的改性聚丙烯的三个成分,所述改性聚丙烯通过将至少(1)0.01〜2重量%的不饱和酸(2 )0.1〜3重量%的不饱和硅烷和(3)结晶聚丙烯中的有机过氧化物,(b)10〜35重量%的玻璃纤维,(c)15〜45重量%的云母粉末 ,组分(b)和(c)与组分(a)混合,使得组分(b)和(c)的总量可以在25至60重量%的范围内,基于 组成。

    Serum remnant-like lipoprotein concentration regulator
    5.
    发明授权
    Serum remnant-like lipoprotein concentration regulator 有权
    血清残留样脂蛋白浓度调节剂

    公开(公告)号:US07378107B2

    公开(公告)日:2008-05-27

    申请号:US11222741

    申请日:2005-09-12

    摘要: The present invention discloses serum remnant-like lipoprotein concentration regulators containing triglyceride of medium-chain fatty acids, wherein 90% or more by weight of the fatty acids as components of the medium-chain triglyceride are saturated fatty acids having 8 and 10 carbon atoms; weight ratio between the saturated fatty acids having 8 carbon atoms and those having 10 carbon atoms is 60/40 to 85/15; and the proportion of the saturated fatty acids having 8 carbon atoms in all the fatty acids bonding to the second position of the triglyceride is 60 to 85 % by weight. The present invention also discloses foods for controlling the concentration of serum remnant-like lipoproteins and pharmaceutical compositions for controlling the concentration of serum remnant-like lipoproteins, which contain the serum remnant-like lipoprotein concentration regulator. The foods for controlling the concentration of serum remnant-like lipoproteins can be easily used without concerning about side effects and restrictive diet.

    摘要翻译: 本发明公开了含有中链脂肪酸甘油三酯的血清残余样脂蛋白浓度调节剂,其中作为中链甘油三酯成分的脂肪酸的90重量%以上为碳原子数为8〜10的饱和脂肪酸, 具有8个碳原子的饱和脂肪酸与具有10个碳原子的饱和脂肪酸之间的重量比为60/40至85/15; 在与甘油三酯的第二位置结合的所有脂肪酸中具有8个碳原子的饱和脂肪酸的比例为60〜85重量%。 本发明还公开了用于控制血清残余样脂蛋白浓度的食品和用于控制含有血清残余样脂蛋白浓度调节剂的血清残余样脂蛋白浓度的药物组合物。 用于控制血清残余样脂蛋白浓度的食物可以容易地使用,而不涉及副作用和限制性饮食。

    Data replication method
    6.
    发明申请
    Data replication method 审中-公开
    数据复制方法

    公开(公告)号:US20050138089A1

    公开(公告)日:2005-06-23

    申请号:US10979113

    申请日:2004-11-03

    申请人: Michio Kasai

    发明人: Michio Kasai

    IPC分类号: G06F12/00 G06F17/30

    摘要: Replication source data is accessed in units of physical blocks as is conventional, and the entire volume is transmitted to a replication destination. In the replication destination, the received data is stored as a file. In this case, the file is managed using a file system according to a replication destination operating system. Since a volume is managed as a file, there is no need for their respective types of replication source and destination operating systems to be the same, and there is also no need for their respective volume sizes to be the same.

    摘要翻译: 复制源数据以传统的物理块为单位进行访问,整个卷被传输到复制目的地。 在复制目的地,接收到的数据被存储为文件。 在这种情况下,根据复制目的地操作系统使用文件系统管理该文件。 由于将卷作为文件进行管理,所以不需要其各自的复制源和目标操作系统的类型相同,并且也不需要它们各自的卷大小相同。

    Serum remnant-like lipoprotein concentration regulator
    9.
    发明申请
    Serum remnant-like lipoprotein concentration regulator 有权
    血清残留样脂蛋白浓度调节剂

    公开(公告)号:US20060034896A1

    公开(公告)日:2006-02-16

    申请号:US11222741

    申请日:2005-09-12

    IPC分类号: A61K47/00 A61K31/225

    摘要: The present invention discloses serum remnant-like lipoprotein concentration regulators containing triglyceride of medium-chain fatty acids, wherein 90% or more by weight of the fatty acids as components of the medium-chain triglyceride are saturated fatty acids having 8 and 10 carbon atoms; weight ratio between the saturated fatty acids having 8 carbon atoms and those having 10 carbon atoms is 60/40 to 85/15; and the proportion of the saturated fatty acids having 8 carbon atoms in all the fatty acids bonding to the second position of the triglyceride is 60 to 85 % by weight. The present invention also discloses foods for controlling the concentration of serum remnant-like lipoproteins and pharmaceutical compositions for controlling the concentration of serum remnant-like lipoproteins, which contain the serum remnant-like lipoprotein concentration regulator. The foods for controlling the concentration of serum remnant-like lipoproteins can be easily used without concerning about side effects and restrictive diet.

    摘要翻译: 本发明公开了含有中链脂肪酸甘油三酯的血清残余样脂蛋白浓度调节剂,其中作为中链甘油三酯成分的脂肪酸的90重量%以上为碳原子数为8〜10的饱和脂肪酸, 具有8个碳原子的饱和脂肪酸与具有10个碳原子的饱和脂肪酸之间的重量比为60/40至85/15; 在与甘油三酯的第二位置结合的所有脂肪酸中具有8个碳原子的饱和脂肪酸的比例为60〜85重量%。 本发明还公开了用于控制血清残余样脂蛋白浓度的食品和用于控制含有血清残余样脂蛋白浓度调节剂的血清残余样脂蛋白浓度的药物组合物。 用于控制血清残余样脂蛋白浓度的食物可以容易地使用,而不涉及副作用和限制性饮食。